NYSE · ASH
Basic Materials · Chemicals - Specialty
$72.78
Up+$0.46 (+0.64%)
Updated Oct 28, 2026, 7:09 AM
SID Score
6.5/10
Composite research score
Smart Money
58/100
Neutral
Price performance · ASH
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 27, 2026
ASH closed at $72.78 after 21 trading sessions, up 6.34% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | $72.26 | $73.23 | $72.025 | $72.78 | 339.05K |
| Oct 26, 2026 | $73.04 | $73.55 | $72.0775 | $72.32 | 332.65K |
| Oct 23, 2026 | $72.95 | $73.47 | $72.11 | $72.99 | 427.34K |
| Oct 22, 2026 | $72.51 | $73.755 | $71.00 | $73.57 | 440.12K |
| Oct 21, 2026 | $71.65 | $72.445 | $71.10 | $72.14 | 407.76K |
| Oct 20, 2026 | $71.25 | $72.16 | $71.25 | $71.69 | 526.63K |
| Oct 19, 2026 | $71.59 | $71.99 | $71.00 | $71.19 | 343.47K |
| Oct 16, 2026 | $71.65 | $73.05 | $70.99 | $71.15 | 430K |
| Oct 15, 2026 | $71.31 | $71.97 | $70.80 | $71.59 | 457.06K |
| Oct 14, 2026 | $72.13 | $72.77 | $70.3901 | $71.32 | 459.01K |
| Oct 13, 2026 | $71.20 | $73.06 | $70.625 | $72.65 | 388.86K |
| Oct 12, 2026 | $70.16 | $71.53 | $70.16 | $70.78 | 459.23K |
| Oct 9, 2026 | $70.56 | $71.065 | $69.95 | $70.57 | 408.77K |
| Oct 8, 2026 | $69.88 | $71.16 | $69.88 | $70.69 | 441.56K |
| Oct 7, 2026 | $70.62 | $72.08 | $70.32 | $70.67 | 906.79K |
| Oct 6, 2026 | $69.35 | $71.7194 | $69.35 | $70.97 | 1.08M |
| Oct 5, 2026 | $68.97 | $69.23 | $68.165 | $68.78 | 539.11K |
| Oct 2, 2026 | $69.17 | $69.88 | $68.7463 | $69.52 | 501.06K |
| Oct 1, 2026 | $67.25 | $68.965 | $67.00 | $68.61 | 564.38K |
| Sep 30, 2026 | $68.70 | $68.755 | $67.54 | $67.92 | 568.57K |
| Sep 29, 2026 | $67.94 | $68.54 | $67.15 | $68.44 | 687.12K |
The latest Smart Investors Daily articles mentioning ASH.
Company
Market Activity
Research & News
ASH research
Company profile and research snapshot.
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 5, 2026 | UBS | Buy | — |
| Aug 6, 2026 | Morgan Stanley | Equal-Weight | — |
| Jul 31, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 30, 2026 | UBS | Buy | — |
| Jul 30, 2026 | Evercore ISI Group | In-Line | — |
No generated briefing is available yet.
Yahoo · Oct 21, 2026
PPG launches TESLIN ENVOS synthetic paper with 30% bio-based content, reducing carbon footprint by up to 25% while enhancing durability, strength and flexibility.
Benzinga · Oct 5, 2026
UBS analyst Joshua Spector maintains Ashland (NYSE:ASH) with a Buy and lowers the price target from $83 to $80.
Yahoo · Oct 3, 2026
Why Ashland’s new crop formulation dispersant matters for shareholders Ashland (ASH) has launched Agrimer Eco-Disperse OD TVO, a patented, nature-based polymeric dispersant for non-aqueous crop protection products. The move is putting fresh attention on how this specialty ingredients business earns its money in agriculture. The product targets a practical problem for agrochemical formulators. They need high performing, more sustainable mixtures that stay stable in the tank, pass tightening...
Yahoo · Sep 25, 2026
Ashland (NYSE:ASH) has long anchored its investment thesis on consistent operating cash flow generation, high free cash flow conversion routinely exceeding 90%, and disciplined balance sheet capital allocation. Even in an elevated interest rate environment where borrowing costs penalize balance sheet expansion, strategically increasing leverage remains a prudent move when capital is directed into high-barrier, […]
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ASH.
